TYK2 and IL-23 Pathway Therapies in Psoriasis: Associations With IL-6, Tryptophan Metabolism, and Depressive Symptoms. Lin L, Dong C, Wu G, Zhu X, et al. Int J Dermatol 2026 Jan 12. doi: 10.1111/ijd.70230.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lin L, Dong C, Wu G, Zhu X, et al. TYK2 and IL-23 Pathway Therapies in Psoriasis: Associations With IL-6, Tryptophan Metabolism, and Depressive Symptoms. Int J Dermatol 2026 Jan 12. doi: 10.1111/ijd.70230.
PMID: 41524454